Rubén Darío Flores Saaib
Academic Startups, Venture Capital and Corporate Business Development Lead at General Inception- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
-
Spanish Native or bilingual proficiency
-
English Native or bilingual proficiency
Topline Score
Bio
Lubo Isakovic, PhD, MBA
I strongly endorse Rubén as a leader and Executive Licensing Professional and his ability to manage a complex team and achieve superior results in a short span of time. While at UCSD, Rubén established himself as an ambassador of the office promoting UCSD in the biotech and hi-tech community. Internally, he was great in managing difficult relationships and he was able to gain the trust of the faculty inventors and UCSD leadership. He is always exploring new ways to structure licenses and other business transactions in order to overcome obstacles in negotiations. As a supervisor, Rubén was clear in his directions, while providing me with the operational freedom to achieve my licensing and business development goals. I hope our paths cross again and I would welcome an opportunity to work with him again
Michael J. Boyer
I strongly recommend Rubén for his management, leadership and teambuilding skills. I have known Rubén since 2000 when we worked together at BD/Pharmingen and since then our paths have crossed several times in our careers. Most recently, we both worked at UC San Diego in the Office of Innovation and Commercialization (OIC) where Rubén was my supervisor for my marketing role ; he allowed me to explore new ways in which we could reach out to industry and partners and encouraged me to play a more active role in the pitching of technologies across the board, life or physical sciences. Rubén was brought to change the mindset of OIC at UC San Diego and was very successful at it, doubling the annual number of startups coming from UC San Diego, and increasing the total number of licenses by creating programs that reached out to the business community. If you know Rubén, he is a master at networking and has an infectious entrepreneurial sprit and a keen sense of what needs to happen to close a deal or a drive a win-win business relationship. Rubén is very well known locally in the San Diego area, but also in the Southern California region and in some global innovation circles. I can highly recommend my friend Rubén and I miss his contagious laugh around the office.
Lubo Isakovic, PhD, MBA
I strongly endorse Rubén as a leader and Executive Licensing Professional and his ability to manage a complex team and achieve superior results in a short span of time. While at UCSD, Rubén established himself as an ambassador of the office promoting UCSD in the biotech and hi-tech community. Internally, he was great in managing difficult relationships and he was able to gain the trust of the faculty inventors and UCSD leadership. He is always exploring new ways to structure licenses and other business transactions in order to overcome obstacles in negotiations. As a supervisor, Rubén was clear in his directions, while providing me with the operational freedom to achieve my licensing and business development goals. I hope our paths cross again and I would welcome an opportunity to work with him again
Michael J. Boyer
I strongly recommend Rubén for his management, leadership and teambuilding skills. I have known Rubén since 2000 when we worked together at BD/Pharmingen and since then our paths have crossed several times in our careers. Most recently, we both worked at UC San Diego in the Office of Innovation and Commercialization (OIC) where Rubén was my supervisor for my marketing role ; he allowed me to explore new ways in which we could reach out to industry and partners and encouraged me to play a more active role in the pitching of technologies across the board, life or physical sciences. Rubén was brought to change the mindset of OIC at UC San Diego and was very successful at it, doubling the annual number of startups coming from UC San Diego, and increasing the total number of licenses by creating programs that reached out to the business community. If you know Rubén, he is a master at networking and has an infectious entrepreneurial sprit and a keen sense of what needs to happen to close a deal or a drive a win-win business relationship. Rubén is very well known locally in the San Diego area, but also in the Southern California region and in some global innovation circles. I can highly recommend my friend Rubén and I miss his contagious laugh around the office.
Lubo Isakovic, PhD, MBA
I strongly endorse Rubén as a leader and Executive Licensing Professional and his ability to manage a complex team and achieve superior results in a short span of time. While at UCSD, Rubén established himself as an ambassador of the office promoting UCSD in the biotech and hi-tech community. Internally, he was great in managing difficult relationships and he was able to gain the trust of the faculty inventors and UCSD leadership. He is always exploring new ways to structure licenses and other business transactions in order to overcome obstacles in negotiations. As a supervisor, Rubén was clear in his directions, while providing me with the operational freedom to achieve my licensing and business development goals. I hope our paths cross again and I would welcome an opportunity to work with him again
Michael J. Boyer
I strongly recommend Rubén for his management, leadership and teambuilding skills. I have known Rubén since 2000 when we worked together at BD/Pharmingen and since then our paths have crossed several times in our careers. Most recently, we both worked at UC San Diego in the Office of Innovation and Commercialization (OIC) where Rubén was my supervisor for my marketing role ; he allowed me to explore new ways in which we could reach out to industry and partners and encouraged me to play a more active role in the pitching of technologies across the board, life or physical sciences. Rubén was brought to change the mindset of OIC at UC San Diego and was very successful at it, doubling the annual number of startups coming from UC San Diego, and increasing the total number of licenses by creating programs that reached out to the business community. If you know Rubén, he is a master at networking and has an infectious entrepreneurial sprit and a keen sense of what needs to happen to close a deal or a drive a win-win business relationship. Rubén is very well known locally in the San Diego area, but also in the Southern California region and in some global innovation circles. I can highly recommend my friend Rubén and I miss his contagious laugh around the office.
Lubo Isakovic, PhD, MBA
I strongly endorse Rubén as a leader and Executive Licensing Professional and his ability to manage a complex team and achieve superior results in a short span of time. While at UCSD, Rubén established himself as an ambassador of the office promoting UCSD in the biotech and hi-tech community. Internally, he was great in managing difficult relationships and he was able to gain the trust of the faculty inventors and UCSD leadership. He is always exploring new ways to structure licenses and other business transactions in order to overcome obstacles in negotiations. As a supervisor, Rubén was clear in his directions, while providing me with the operational freedom to achieve my licensing and business development goals. I hope our paths cross again and I would welcome an opportunity to work with him again
Michael J. Boyer
I strongly recommend Rubén for his management, leadership and teambuilding skills. I have known Rubén since 2000 when we worked together at BD/Pharmingen and since then our paths have crossed several times in our careers. Most recently, we both worked at UC San Diego in the Office of Innovation and Commercialization (OIC) where Rubén was my supervisor for my marketing role ; he allowed me to explore new ways in which we could reach out to industry and partners and encouraged me to play a more active role in the pitching of technologies across the board, life or physical sciences. Rubén was brought to change the mindset of OIC at UC San Diego and was very successful at it, doubling the annual number of startups coming from UC San Diego, and increasing the total number of licenses by creating programs that reached out to the business community. If you know Rubén, he is a master at networking and has an infectious entrepreneurial sprit and a keen sense of what needs to happen to close a deal or a drive a win-win business relationship. Rubén is very well known locally in the San Diego area, but also in the Southern California region and in some global innovation circles. I can highly recommend my friend Rubén and I miss his contagious laugh around the office.
Credentials
-
RTTP | Registered Technology Transfer Professional
ATTPMay, 2023- Nov, 2024 -
VC University ONLINE
VC UniversityJul, 2022- Nov, 2024 -
Negotiating the Nonnegotiable (Blinkist Summary)
LinkedInMay, 2022- Nov, 2024 -
Certified Licensing Professional
Licensing Executives Society (U.S.A. and Canada), Inc.Jun, 2021- Nov, 2024 -
CLP
Certified Licensing Professionals, Inc.May, 2021- Nov, 2024
Experience
-
General Inception
-
United States
-
Venture Capital and Private Equity Principals
-
1 - 100 Employee
-
Academic Startups, Venture Capital and Corporate Business Development Lead
-
Aug 2022 - Present
General Inception partners with inventors to ignite innovation and create transformational companies. We are co-founders bringing together domain expertise, seasoned executive talent, infrastructure resources, and capital to nurture company growth from inception. Learn more about us and our portfolio here: https://www.generalinception.com. You can reach me at ruben.flores@generalinception.com General Inception partners with inventors to ignite innovation and create transformational companies. We are co-founders bringing together domain expertise, seasoned executive talent, infrastructure resources, and capital to nurture company growth from inception. Learn more about us and our portfolio here: https://www.generalinception.com. You can reach me at ruben.flores@generalinception.com
-
-
-
Regain BioMedicals
-
United States
-
Medical Equipment Manufacturing
-
Interim Chief Executive Officer
-
May 2022 - Present
Regain BioMedicals developed "GRACE", a patented, wearable, novel, non-invasive, personalized, non-neuronal-based and patented device to reduce or eliminate essential tremor. Our device helps patients with essential tremors regain control and increase their quality of life. Regain BioMedicals is also testing the use of its technology platform for the treatment of other involuntary tremors. Regain BioMedicals developed "GRACE", a patented, wearable, novel, non-invasive, personalized, non-neuronal-based and patented device to reduce or eliminate essential tremor. Our device helps patients with essential tremors regain control and increase their quality of life. Regain BioMedicals is also testing the use of its technology platform for the treatment of other involuntary tremors.
-
-
-
University of Southern California
-
United States
-
Higher Education
-
700 & Above Employee
-
Associate Director of Technology Licensing
-
Apr 2019 - Jul 2022
At the University of Southern California, I manage a talented group of Licensing Associates to commercialize the innovations created on campus for the benefit of society. Our team focus is on software, the creative arts, social studies, materials, medical devices, telecommunications, entertainment, renewable and alternative energy, biologicals therapeutics and bioengineering. At the University of Southern California, I manage a talented group of Licensing Associates to commercialize the innovations created on campus for the benefit of society. Our team focus is on software, the creative arts, social studies, materials, medical devices, telecommunications, entertainment, renewable and alternative energy, biologicals therapeutics and bioengineering.
-
-
-
San Diego Innovation Council
-
United States
-
International Trade and Development
-
1 - 100 Employee
-
Co-Founder, President, and Board Member
-
Dec 2016 - Jan 2022
The San Diego Innovation Council (SDIC) convenes the region's premier research-intensive academic centers, along with the organizations that support academic derived inventions. The Council promotes a shared vision for growth through innovation, entrepreneurial activities, and education. Members are committed to supporting commercialization, investment, and new company formation. Through quarterly meetings, and an annual Innovation Showcase in the Fall, the Council aims to reinforce and… Show more The San Diego Innovation Council (SDIC) convenes the region's premier research-intensive academic centers, along with the organizations that support academic derived inventions. The Council promotes a shared vision for growth through innovation, entrepreneurial activities, and education. Members are committed to supporting commercialization, investment, and new company formation. Through quarterly meetings, and an annual Innovation Showcase in the Fall, the Council aims to reinforce and enhance the economic impact of the greater San Diego region. During the Showcase, the SDIC brings together 30+ technology companies that have a foundation in academic research, along with investors, service providers and entrepreneurs seeking leadership opportunities. Organizations from around the globe attend the annual showcase, including investors from the UK, France, Boston, San Francisco, Asia and Latin America. Show less The San Diego Innovation Council (SDIC) convenes the region's premier research-intensive academic centers, along with the organizations that support academic derived inventions. The Council promotes a shared vision for growth through innovation, entrepreneurial activities, and education. Members are committed to supporting commercialization, investment, and new company formation. Through quarterly meetings, and an annual Innovation Showcase in the Fall, the Council aims to reinforce and… Show more The San Diego Innovation Council (SDIC) convenes the region's premier research-intensive academic centers, along with the organizations that support academic derived inventions. The Council promotes a shared vision for growth through innovation, entrepreneurial activities, and education. Members are committed to supporting commercialization, investment, and new company formation. Through quarterly meetings, and an annual Innovation Showcase in the Fall, the Council aims to reinforce and enhance the economic impact of the greater San Diego region. During the Showcase, the SDIC brings together 30+ technology companies that have a foundation in academic research, along with investors, service providers and entrepreneurs seeking leadership opportunities. Organizations from around the globe attend the annual showcase, including investors from the UK, France, Boston, San Francisco, Asia and Latin America. Show less
-
-
-
UC San Diego
-
United States
-
Higher Education
-
700 & Above Employee
-
Director of Commercialization
-
Feb 2016 - Jan 2019
At UC San Diego, my team of 18 licensing managers, and marketing and intellectual property professionals doubled the number of annual startup creation to 32, increased annual licenses 50% to 120 and reduced average time to license completion to six weeks. Part of my role was to implement culture-changing initiatives to focus on customer service, creating productive relationships between UCSD and the business and campus community. I also focused on developing partnerships with entrepreneurs as… Show more At UC San Diego, my team of 18 licensing managers, and marketing and intellectual property professionals doubled the number of annual startup creation to 32, increased annual licenses 50% to 120 and reduced average time to license completion to six weeks. Part of my role was to implement culture-changing initiatives to focus on customer service, creating productive relationships between UCSD and the business and campus community. I also focused on developing partnerships with entrepreneurs as well as angel, strategic and venture capital investors to support UCSD commercialization activities. From the receipt and management of new invention disclosures to engagement in collaborations across different schools in campus, and the creation of entrepreneurial programs with our local partners, we removed barriers and make campus resources accessible to anyone who wishes to learn how to commercialize a new invention. Show less At UC San Diego, my team of 18 licensing managers, and marketing and intellectual property professionals doubled the number of annual startup creation to 32, increased annual licenses 50% to 120 and reduced average time to license completion to six weeks. Part of my role was to implement culture-changing initiatives to focus on customer service, creating productive relationships between UCSD and the business and campus community. I also focused on developing partnerships with entrepreneurs as… Show more At UC San Diego, my team of 18 licensing managers, and marketing and intellectual property professionals doubled the number of annual startup creation to 32, increased annual licenses 50% to 120 and reduced average time to license completion to six weeks. Part of my role was to implement culture-changing initiatives to focus on customer service, creating productive relationships between UCSD and the business and campus community. I also focused on developing partnerships with entrepreneurs as well as angel, strategic and venture capital investors to support UCSD commercialization activities. From the receipt and management of new invention disclosures to engagement in collaborations across different schools in campus, and the creation of entrepreneurial programs with our local partners, we removed barriers and make campus resources accessible to anyone who wishes to learn how to commercialize a new invention. Show less
-
-
-
The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
-
United States
-
Research Services
-
300 - 400 Employee
-
Vice President Business Development
-
Apr 2013 - Feb 2016
Reporting to the CEO, at LA BioMed, I led the group managing the intellectual property portfolio and business relationships. LA BioMed's portfolio included over 200 granted patents in the US and dozens of international patents. My team also managed business relationships with commercial partners funding sponsored research and running over dozens of clinical trials annually at Harbor-UCLA Medical Center. LA BioMed (now The Lundquist Institute) is a non-profit, private research… Show more Reporting to the CEO, at LA BioMed, I led the group managing the intellectual property portfolio and business relationships. LA BioMed's portfolio included over 200 granted patents in the US and dozens of international patents. My team also managed business relationships with commercial partners funding sponsored research and running over dozens of clinical trials annually at Harbor-UCLA Medical Center. LA BioMed (now The Lundquist Institute) is a non-profit, private research organization located in the Harbor-UCLA Medical Campus in Torrance. Founded in the 1950's, with over 100 active physician researchers and 300,000 sq feet of research space, LA BioMed has been the cradle of innovations such as the modern cholesterol test, surfactants for preemies, Aldurazyme, the nurse practitioner program, the paramedics program and Emmaus Medical, QT Medical and many others. With a strong track record of successful commercialization of clinical technologies in the form of spin-offs, we nurtured this approach, partnering long-term and sharing the potential risk and success with interested parties in the following areas: endocrinology, medical devices, cardiovascular imaging, metabolic disorders, rare genetic diseases, nephrology and pulmonology. Show less Reporting to the CEO, at LA BioMed, I led the group managing the intellectual property portfolio and business relationships. LA BioMed's portfolio included over 200 granted patents in the US and dozens of international patents. My team also managed business relationships with commercial partners funding sponsored research and running over dozens of clinical trials annually at Harbor-UCLA Medical Center. LA BioMed (now The Lundquist Institute) is a non-profit, private research… Show more Reporting to the CEO, at LA BioMed, I led the group managing the intellectual property portfolio and business relationships. LA BioMed's portfolio included over 200 granted patents in the US and dozens of international patents. My team also managed business relationships with commercial partners funding sponsored research and running over dozens of clinical trials annually at Harbor-UCLA Medical Center. LA BioMed (now The Lundquist Institute) is a non-profit, private research organization located in the Harbor-UCLA Medical Campus in Torrance. Founded in the 1950's, with over 100 active physician researchers and 300,000 sq feet of research space, LA BioMed has been the cradle of innovations such as the modern cholesterol test, surfactants for preemies, Aldurazyme, the nurse practitioner program, the paramedics program and Emmaus Medical, QT Medical and many others. With a strong track record of successful commercialization of clinical technologies in the form of spin-offs, we nurtured this approach, partnering long-term and sharing the potential risk and success with interested parties in the following areas: endocrinology, medical devices, cardiovascular imaging, metabolic disorders, rare genetic diseases, nephrology and pulmonology. Show less
-
-
-
GenWay Biotech, subsidiary of Aviva Systems Biology
-
United States
-
Biotechnology
-
1 - 100 Employee
-
Vice President Catalog and Custom Business
-
Jan 2013 - Apr 2013
Founded in 1998, GenWay Biotech provides reagents and tools for the Life Sciences market and CLIA laboratory services. At GenWay I managed the strategic planning and operational activities of the custom services business unit, producing specialty reagents and biological assays as OEM services for major diagnostic companies in the US and abroad. In this capacity we expanded the customer base of Genway and secured various contracts to ensure future delivery of specialty reagents… Show more Founded in 1998, GenWay Biotech provides reagents and tools for the Life Sciences market and CLIA laboratory services. At GenWay I managed the strategic planning and operational activities of the custom services business unit, producing specialty reagents and biological assays as OEM services for major diagnostic companies in the US and abroad. In this capacity we expanded the customer base of Genway and secured various contracts to ensure future delivery of specialty reagents. While at Genway we also implemented operational and marketing improvements to the catalog services unit (antibodies, recombinant proteins, ELISA assays and secondary antibodies) resulting in a 20% increase in net sales. Show less Founded in 1998, GenWay Biotech provides reagents and tools for the Life Sciences market and CLIA laboratory services. At GenWay I managed the strategic planning and operational activities of the custom services business unit, producing specialty reagents and biological assays as OEM services for major diagnostic companies in the US and abroad. In this capacity we expanded the customer base of Genway and secured various contracts to ensure future delivery of specialty reagents… Show more Founded in 1998, GenWay Biotech provides reagents and tools for the Life Sciences market and CLIA laboratory services. At GenWay I managed the strategic planning and operational activities of the custom services business unit, producing specialty reagents and biological assays as OEM services for major diagnostic companies in the US and abroad. In this capacity we expanded the customer base of Genway and secured various contracts to ensure future delivery of specialty reagents. While at Genway we also implemented operational and marketing improvements to the catalog services unit (antibodies, recombinant proteins, ELISA assays and secondary antibodies) resulting in a 20% increase in net sales. Show less
-
-
-
MilliporeSigma
-
United States
-
Biotechnology Research
-
700 & Above Employee
-
Business Development Consultant and Scientific Affairs Manager (Merck KGaA)
-
Aug 2007 - Nov 2012
EMD Millipore is a decades old organization which provides reagents, tools, services and solutions to biopharma, large pharma, basic research and water management organizations. At EMD Millipore my team supported the $1billion annual sales Bioscience Division. I was responsible for retooling the scientific consultant management process to extract real value for new product introduction for EMD Millipore. Our team implemented a world-class process for the presentation, review and timely… Show more EMD Millipore is a decades old organization which provides reagents, tools, services and solutions to biopharma, large pharma, basic research and water management organizations. At EMD Millipore my team supported the $1billion annual sales Bioscience Division. I was responsible for retooling the scientific consultant management process to extract real value for new product introduction for EMD Millipore. Our team implemented a world-class process for the presentation, review and timely decision-making of thousands of new opportunities brought to teams across all geographical locations in the Biosciences Division of EMD Millipore. My team was responsible for actively managing key strategic collaborations with a network of 50+ academic scientific consultants and partners for the Bioscience Division of Millipore towards the development of novel reagents, products and services in the areas of Clinical Diagnostics, Biomarkers, Cell Biology, Neurobiology, Stem Cells, Signal Transduction, Post-Translational Modifications, Microfluidics, Protein Separation and High Content Screening. My role as an individual contributor included negotiating business terms, facilitate the execution of licensing agreements and participate in the completion of new product development up until market launch. Our team promoted the recognition of Millipore’s in house R&D capabilities in the scientific community and elevated the profile of Millipore scientists by fostering publications in peer-reviewed journals. Finally, using my expertise in the development, approval and marketing of diagnostic products, I facilitated the workflow between marketing, R&D and regulatory affairs on the design and execution of a business strategies for the regulatory clearance of flow-based diagnostic products for CD4+ monitoring in immunocompromised patients.
-
-
Sr. Manager R&D/Marketing Diagnostic Products and Luminex
-
Nov 2005 - Aug 2007
As and R&D and Marketing manager, I was responsible for hiring, coaching and mentoring staff and introducing a process for revamping the new product development and regulatory approval efforts of the clinical diagnostics group. In this capacity I managed the groups performing US and world wide clinical operations, research and development and marketing activities for Chemicon's Simulfluor and LightDiagnostics FDA 510(k) and CE regulated diagnostics products. The focus of this group was on the… Show more As and R&D and Marketing manager, I was responsible for hiring, coaching and mentoring staff and introducing a process for revamping the new product development and regulatory approval efforts of the clinical diagnostics group. In this capacity I managed the groups performing US and world wide clinical operations, research and development and marketing activities for Chemicon's Simulfluor and LightDiagnostics FDA 510(k) and CE regulated diagnostics products. The focus of this group was on the development of diagnostic kits for the detection of respiratory viruses, herpesviruses and enteroviruses in direct and/or cultured patient specimens. During this time I was also responsible for building a group and managing the research and development and manufacturing activities of 14 associates working on over 400 products related to cytokines and cell signaling targets in the Beadlyte product line based on the Luminex platform. One of my first tasks at Serologicals (later EMD Millipore) was to oversee the successful transition of the Luminex Beadlyte portfolio from Lake Placid, NY to Temecula, CA while managing two teams at two different sites. During my tenure in this role I managed the collaborations with academic scientists at Yale and our team developed the FIRST serum-based multiplex biomarker assay for the detection of ovarian cancer.
-
-
-
Abbott
-
United States
-
Hospitals and Health Care
-
700 & Above Employee
-
Clinical Scientist and Collaborative Agreements Manager
-
Jan 2004 - Sep 2005
At Biosite (now Abbott), I was responsible for the design, implementation and management of clinical trials aimed at the discovery of novel plasma biomarkers for sepsis and cardiovascular disease. In this role, I initiated and managed a large, 1000 patient, 10 center, US clinical trial for the identification of plasma serum biomarkers in patients presenting with sepsis at the ED. As a member of the strategic guidance group for new biomarker development in R&D, I investigated, prioritized… Show more At Biosite (now Abbott), I was responsible for the design, implementation and management of clinical trials aimed at the discovery of novel plasma biomarkers for sepsis and cardiovascular disease. In this role, I initiated and managed a large, 1000 patient, 10 center, US clinical trial for the identification of plasma serum biomarkers in patients presenting with sepsis at the ED. As a member of the strategic guidance group for new biomarker development in R&D, I investigated, prioritized and recommended the development of specific immuno-assays to novel biomarker targets in plasma. During my tenure at Biosite, I was also responsible for negotiating and executing collaborative agreements for the measurement and discovery of novel biomarkers during drug-based or clinical trials with hospitals and biotechnology companies across the United States. Show less At Biosite (now Abbott), I was responsible for the design, implementation and management of clinical trials aimed at the discovery of novel plasma biomarkers for sepsis and cardiovascular disease. In this role, I initiated and managed a large, 1000 patient, 10 center, US clinical trial for the identification of plasma serum biomarkers in patients presenting with sepsis at the ED. As a member of the strategic guidance group for new biomarker development in R&D, I investigated, prioritized… Show more At Biosite (now Abbott), I was responsible for the design, implementation and management of clinical trials aimed at the discovery of novel plasma biomarkers for sepsis and cardiovascular disease. In this role, I initiated and managed a large, 1000 patient, 10 center, US clinical trial for the identification of plasma serum biomarkers in patients presenting with sepsis at the ED. As a member of the strategic guidance group for new biomarker development in R&D, I investigated, prioritized and recommended the development of specific immuno-assays to novel biomarker targets in plasma. During my tenure at Biosite, I was also responsible for negotiating and executing collaborative agreements for the measurement and discovery of novel biomarkers during drug-based or clinical trials with hospitals and biotechnology companies across the United States. Show less
-
-
-
BD
-
United States
-
Medical Equipment Manufacturing
-
700 & Above Employee
-
Scientist
-
Sep 2000 - Dec 2003
At BD Biosciences I was responsible for the development of novel immunohistochemical and in situ hibridization reagents for the detection of Th1 and Th2 type cytokines in the Immunopathology group. I managed the work flow for the development of antibody based assays for phospho-specific targets in cell signaling molecules from target selection and antigen design to screening strategies and validation. I also managed the cell culture and ab validation group in the Cell Biology group at… Show more At BD Biosciences I was responsible for the development of novel immunohistochemical and in situ hibridization reagents for the detection of Th1 and Th2 type cytokines in the Immunopathology group. I managed the work flow for the development of antibody based assays for phospho-specific targets in cell signaling molecules from target selection and antigen design to screening strategies and validation. I also managed the cell culture and ab validation group in the Cell Biology group at BD PharMingen and develop protocols for intracellular staining in flow cytometry applications At BD I was also responsible for collaborative projects in antibody development with academics and other units of BD Biosciences, an experience that provided me with a launchpad towards my focus in business development and clinical trial management. Show less At BD Biosciences I was responsible for the development of novel immunohistochemical and in situ hibridization reagents for the detection of Th1 and Th2 type cytokines in the Immunopathology group. I managed the work flow for the development of antibody based assays for phospho-specific targets in cell signaling molecules from target selection and antigen design to screening strategies and validation. I also managed the cell culture and ab validation group in the Cell Biology group at… Show more At BD Biosciences I was responsible for the development of novel immunohistochemical and in situ hibridization reagents for the detection of Th1 and Th2 type cytokines in the Immunopathology group. I managed the work flow for the development of antibody based assays for phospho-specific targets in cell signaling molecules from target selection and antigen design to screening strategies and validation. I also managed the cell culture and ab validation group in the Cell Biology group at BD PharMingen and develop protocols for intracellular staining in flow cytometry applications At BD I was also responsible for collaborative projects in antibody development with academics and other units of BD Biosciences, an experience that provided me with a launchpad towards my focus in business development and clinical trial management. Show less
-
-
Education
-
1994 - 2000
University of California, Los Angeles
Ph.D., Biochemistry and Molecular Biology -
1988 - 1993
Universidad Autónoma de Baja California
Bachelor's degree, Biology, General
Community
